Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advaxis, Inc.
Advaxis CEO Thomas A. Moore Interviewed
June 26th, 2009
The Wall Street Transcript interviewed CEO Thomas A. Moore of Advaxis, Inc. (OTCBB: ADXS) where he addressed questions regarding the Company's progress and the development of its Listeria-based platform technology. For further information, please visit their website. About Advaxis, Inc. Based in North Brunswick, New Jersey, Advaxis is developing proprietary Listeria monocytogenes (Lm) cancer vaccines based on technology developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania and chairperson of Advaxis' scientific advisory board. Advaxis is developing attenuated live Lm vaccines that deliver engineered tumor antigens, which stimulate multiple...
Source: Health Business Week (2009-06-26)
|
